BTBD9 rs73142231: Sleep Architecture and Motor Movements
The genetic variant rs73142231 is a single nucleotide polymorphism located in the BTBD9 gene on human chromosome 6. Research has identified links between this variant and physiological sleep traits, including nocturnal sleep fragmentation, reduced sleep efficiency, and periodic limb movement indices measured during polysomnography. However, the overall strength of clinical evidence remains limited, and carrying specific alleles indicates subtle population-level statistical differences rather than a medical diagnosis.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Homozygous for the common base state at this locus, which has generally been associated in sleep studies with standard baseline periodic limb movement indices and average nocturnal sleep continuity. This genotype does not eliminate the possibility of encountering poor sleep or movement-related restlessness due to non-genetic or environmental causes. In general population datasets, this configuration serves as the standard comparison group. | Informational |
| CT | Heterozygous carrier possessing one copy of the statistical risk-associated minor allele and one common allele. Sleep research cohorts show that individuals with this profile may display intermediate statistical elevations in periodic limb movements during polysomnography and modest reductions in sleep efficiency. It represents a common, benign variation across global populations rather than an active disorder. | Informational |
| TT | Homozygous for the minor variant allele associated in research with higher periodic limb movement indices and an increased likelihood of nocturnal sleep fragmentation. While this genotype demonstrates the strongest statistical correlation with movement-related sleep disruption in cohort studies, it is not diagnostic of any clinical condition. Many individuals with this genotype experience entirely normal, restorative sleep. | Higher attention |
Genomic Context of rs73142231
The rs73142231 polymorphism resides within an intronic region of the BTBD9 (BTB domain containing 9) gene on chromosome 6. As an intronic single nucleotide polymorphism, it does not alter the primary amino acid coding sequence of the resulting protein directly. Instead, genomic research suggests that variants in this locus may act as regulatory markers or exist in tight linkage disequilibrium with other non-coding regulatory sequences that modulate gene expression levels or alternate splicing mechanisms in neural tissues. Genomic registries such as dbSNP catalogue the standard nucleotide variation at this locus, typically reflecting an allele substitution that segregates widely in human populations. Identifying an individual's status at this position helps researchers evaluate how standard non-coding variability across chromosome 6 correlates with measurable physiological rhythms.
Function of the BTBD9 Gene in Neural Regulation
The BTBD9 gene encodes a protein characterized by a broad-complex, tramtrack, and bric-a-brac (BTB) domain, also known as a POZ domain. While the precise molecular cascade governed by human BTBD9 continues to be clarified, functional biology and animal knockout experiments demonstrate that the protein plays an important role in central nervous system homeostasis. Rodent and Drosophila models lacking functional BTBD9 exhibit motor restlessness during standard rest periods, disruptions in sleep continuity, altered sensory gating, and dysregulation within striatal dopaminergic signaling and cellular iron metabolism pathways. Furthermore, molecular studies suggest that BTBD9 modulates synaptic plasticity and presynaptic vesicle dynamics. Because dopaminergic neurotransmission and iron balance are essential for motor regulation and sleep stability, disruption or subtle variation in BTBD9 activity provides a plausible biological framework for movement-related sleep disturbances.
Research Findings on Sleep Architecture and Movement
Polysomnography and sleep cohort analyses have evaluated variants across BTBD9, including rs73142231, to assess how subtle genetic variation influences nocturnal physiology. Published sleep studies show that specific alleles at this locus correlate with higher periodic limb movement indices (PLMI), increased night-time awakenings (sleep fragmentation), and correspondingly decreased overall sleep efficiency. In sleep medicine cohorts, elevated limb movement frequencies during non-REM sleep disrupt natural sleep stage transitions. Nevertheless, scientific evidence linking rs73142231 directly to distinct clinical outcomes remains classified as limited. Most identified correlations derive from statistical population-wide genome-wide association or candidate locus models, which capture subtle shifts in average nocturnal limb movements rather than severe, deterministic pathology.
Population Genetics and Frequency Patterns
Alleles at the rs73142231 locus demonstrate variable distributions across global demographic ancestries cataloged in genomic databases such as gnomAD. In populations of European ancestry, the minor allele frequency is relatively common, estimated at approximately 0.48. This widespread prevalence indicates that nearly half of the chromosomes sampled in European cohorts carry the minor allele, making heterozygous and homozygous carriers extremely common. Across other continental ancestries, allele frequencies vary, reflecting divergent historical population dynamics and recombination boundaries across chromosome 6. Because the minor allele is so common in healthy reference populations, its presence alone is not indicative of an overt genetic anomaly, but rather a normal component of human genetic diversity.
Clinical Limitations and Everyday Context
Direct-to-consumer genetic profiles and research panels frequently report genotypes at BTBD9 variants, but these markers are not diagnostic tools. Carrying an allele associated with elevated sleep fragmentation or periodic limb movements does not guarantee that an individual will develop restless legs syndrome, periodic limb movement disorder, or chronic insomnia. Complex behavioral traits and sleep architecture are polygenic, shaped by dozens of independent genetic loci alongside environmental factors such as lifestyle, stress, caffeine intake, and ferritin or iron levels. Individuals experiencing unrefreshing sleep or unusual night-time restlessness should consult a qualified healthcare provider for comprehensive clinical evaluation, rather than relying on single-locus genetic data for diagnosis or management decisions.
How common is this variant?
The minor allele at rs73142231 has an estimated frequency of approximately 0.48 in populations of European ancestry, with common representation across multiple global reference cohorts in public genomic datasets.
Frequently asked questions
What does a variant in the BTBD9 gene mean for my sleep quality?
A variant in BTBD9 indicates that you carry a common genetic marker that researchers have statistically linked to subtle differences in sleep architecture, such as higher periodic limb movement indices or slight nocturnal sleep fragmentation. However, these associations are modest and derived from population averages, meaning carrying the variant does not guarantee poor sleep.
Does having the rs73142231 variant mean I have restless legs syndrome?
No, having an associated allele at rs73142231 is not a clinical diagnosis for restless legs syndrome (RLS) or periodic limb movement disorder (PLMD). These conditions require formal medical evaluation based on diagnostic criteria, symptom history, and sometimes clinical sleep studies.
Why is the evidence for rs73142231 classified as limited?
The evidence is considered limited because while genome-wide association and cohort studies detect statistical correlations between BTBD9 variants and sleep fragmentation or limb movements, individual effect sizes are small, and direct causal clinical mechanisms for this specific SNP remain incompletely characterized.
Should I change any medications or sleep supplements based on my genotype?
You should not alter your medications, supplements, or medical therapies based solely on a BTBD9 genetic test result. Any adjustments to treatments or diagnostic workups for sleep disturbances should always be discussed directly with a qualified healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs73142231?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29